Cognitive Impairments
24
2
3
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
92.3%
+5.8% vs benchmark
13%
3 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (24)
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
TIS for Improving Cognitive Impairment in Schizophrenia
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users
Effects of Transcranial Direct Current Stimulation on Cognitive Rehabilitation in Schizophrenia
Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden
Oxidative Stress and Cognitive Dysfunction After COVID-19
RTL Concussion Communication
Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability
Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment.
Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
The "Light for the Brain" Study
Digital Support for People With Cognitive Impairment
Video-Enhanced Care Management for Medically Complex Veterans
LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
Attention & Memory Impairments in Menopausal Women
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program